Change - Announcement of Appointment::Appointment of General Counsel

Issuer & Securities

Issuer/ Manager
MEDTECS INTERNATIONAL CORP LTD
Securities
MEDTECS INTERNATIONAL CORP LTD - BMG5958R1043 - 546
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Appointment
Date &Time of Broadcast
01-Mar-2021 07:32:16
Status
New
Announcement Sub Title
Appointment of General Counsel
Announcement Reference
SG210301OTHRPWBJ
Submitted By (Co./ Ind. Name)
Clement Yang Ker-Cheng
Designation
Executive Chairman
Description (Please provide a detailed description of the event in the box below)
Ms Wan Chien Yang will be appointed as General Counsel of the Company with effect from 1 March 2021.

This announcement has been prepared by the Company and its contents have been reviewed by the Company's sponsor, R & T Corporate Services Pte. Ltd. ("Sponsor"), for compliance with the relevant rules of the Singapore Exchange Securities Trading Limited ("Exchange"). The Sponsor has not independently verified the contents of this announcement including the accuracy or completeness of any of the figures used, statements, opinions or other information made or disclosed.

This announcement has not been examined or approved by the Exchange. The Exchange assumes no responsibility for the contents of this announcement including the correctness of any of the statements or opinions made or reports contained in this announcement.

The contact persons for the Sponsor are Ms Evelyn Wee (Tel no.: +65 6232 0724) and Mr Howard Cheam Heng Haw (Tel no.: +65 6232 0685), R & T Corporate Services Pte. Ltd., at 9 Straits View, Marina One West Tower, #06-07 Singapore 018937.

Additional Details

Date Of Appointment
01/03/2021
Name Of Person
Wan Chien Yang
Age
40
Country Of Principal Residence
Taiwan, Province Of China
The Board's comments on this appointment (including rationale, selection criteria, and the search and nomination process)
The Board has considered and accepted the recommendations of the management and the Nominating Committee to appoint Ms Wan Chien Yang as the Company's General Counsel, after reviewing her educational background, professional qualifications and work experience.
Whether appointment is executive, and if so, the area of responsibility
The appointment is executive. Ms Wan Chien Yang is responsible for discharging, overseeing and coordinating the Company's legal activities and functions to ensure the Company's compliance with and adherence to applicable law, as well as such other services as may be assigned from time to time by the Company.
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
General Counsel
Professional qualifications
Bar Admissions: New York, 2007
New York Law School, Juris Doctor, 2006
New York University, Bachelor of Arts, English, 2003
Any relationship (including immediate family relationships) with any existing director, existing executive officer, the issuer and/ or substantial shareholder of the listed issuer or any of its principal subsidiaries
Daughter of Mr Clement Yang Ker-Cheng (Executive Chairman of the Company) and Ms Sherry Chen Su-Tian (Non-Executive Chairman of Medtecs (Taiwan) Corporation) and sister of Mr William Yang Weiyuan (Deputy Chairman / Executive Director / Chief Executive Officer of the Company).
Conflict of interests (including any competing business)
No conflict of interest.
Working experience and occupation(s) during the past 10 years
Feb 2020 to present: Senior Executive Assistant to Chairman, Medtecs Int'l Co., Ltd., Taipei, Taiwan
2020 to present: Director, Medtecs USA Corporation
2015 to present: Director, Medtecs MSEZ Corp Ltd, Cambodia
2012 to present: Supervisor and Director, Medtecs (Taiwan) Corporation, Taiwan
May 2012 to Jan 2020: Legal Editor, LexisNexis (a division of Reed Elsevier (Greater China) Limited), Hong Kong
Nov 2010 to Jun 2011: Senior Legal Assistant, Sidley Austin LLP, Hong Kong
2005 to 2015: Director, Team Full Investment Co., Ltd., Taiwan
Undertaking submitted to the listed issuer in the form of Appendix 7.7 (Listing Rule 704(7)) Or Appendix 7H (Catalist Rule 704(6))
Yes
Shareholding interest in the listed issuer and its subsidiaries?
No
# These fields are not applicable for announcements of appointments pursuant to Listing Rule 704 (9) or Catalist Rule 704 (8).
Past (for the last 5 years)
Nil
Present
Senior Executive Assistant to Chairman and Director of Medtecs (Taiwan) Corporation, Taiwan, Medtecs USA Corporation and Medtecs MSEZ Corp Ltd, Cambodia
(a) Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner?
No
(b) Whether at any time during the last 10 years, an application or a petition under any law of any jurisdiction was filed against an entity (not being a partnership) of which he was a director or an equivalent person or a key executive, at the time when he was a director or an equivalent person or a key executive of that entity or at any time within 2 years from the date he ceased to be a director or an equivalent person or a key executive of that entity, for the winding up or dissolution of that entity or, where that entity is the trustee of a business trust, that business trust, on the ground of insolvency?
No
(c) Whether there is any unsatisfied judgment against him?
No
(d) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such purpose?
No
(e) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such breach?
No
(f) Whether at any time during the last 10 years, judgment has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misrepresentation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings of which he is aware) involving an allegation of fraud, misrepresentation or dishonesty on his part?
No
(g) Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any entity or business trust?
No
(h) Whether he has ever been disqualified from acting as a director or an equivalent person of any entity (including the trustee of a business trust), or from taking part directly or indirectly in the management of any entity or business trust?
No
(i) Whether he has ever been the subject of any order, judgment or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity?
No
(j) Whether he has ever, to his knowledge, been concerned with the management or conduct, in Singapore or elsewhere, of the affairs of :-
(i) any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; or
No
(ii) any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; or
No
(iii) any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; or
No
(iv) any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust?
No
(k) Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere?
No
Any prior experience as a director of an issuer listed on the Exchange?
No
If no, please state if the director has attended or will be attending training on the roles and responsibilities of a director of a listed issuer as prescribed by the Exchange
Ms. Yang is not appointed as a director of the Company. Notwithstanding the same, the Company will facilitate her attendance at the prescribed first-time director training so she may familiarise herself with the listing rules and requirements of the Exchange.
Please provide details of relevant experience and the nominating committee's reasons for not requiring the director to undergo training as prescribed by the Exchange (if applicable)
Not applicable